Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2026-01-22 @ 4:15 PM
Study NCT ID:
NCT05320159
Status:
COMPLETED
Last Update Posted:
2022-07-01
First Post:
2022-03-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Psoriasis | View |
Keywords: